Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Report 2021
Table of Content
1 Ophthalmology for Age-related Macular Degeneration Diseases Market Overview
- 1.1 Ophthalmology for Age-related Macular Degeneration Diseases Product Scope
- 1.2 Ophthalmology for Age-related Macular Degeneration Diseases Segment by Type
- 1.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Portable
- 1.2.3 Desktop
- 1.3 Ophthalmology for Age-related Macular Degeneration Diseases Segment by Application
- 1.3.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Wet AMD
- 1.3.3 Dry AMD
- 1.4 Ophthalmology for Age-related Macular Degeneration Diseases Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Price Trends (2016-2027)
2 Ophthalmology for Age-related Macular Degeneration Diseases Estimates and Forecasts by Region
- 2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Region (2016-2021)
- 2.2.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue Market Share by Region (2016-2021)
- 2.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Ophthalmology for Age-related Macular Degeneration Diseases Estimates and Projections (2016-2027)
- 2.4.2 Europe Ophthalmology for Age-related Macular Degeneration Diseases Estimates and Projections (2016-2027)
- 2.4.3 China Ophthalmology for Age-related Macular Degeneration Diseases Estimates and Projections (2016-2027)
- 2.4.4 Japan Ophthalmology for Age-related Macular Degeneration Diseases Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Estimates and Projections (2016-2027)
- 2.4.6 India Ophthalmology for Age-related Macular Degeneration Diseases Estimates and Projections (2016-2027)
3 Global Ophthalmology for Age-related Macular Degeneration Diseases Competition Landscape by Players
- 3.1 Global Top Ophthalmology for Age-related Macular Degeneration Diseases Players by Sales (2016-2021)
- 3.2 Global Top Ophthalmology for Age-related Macular Degeneration Diseases Players by Revenue (2016-2021)
- 3.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ophthalmology for Age-related Macular Degeneration Diseases as of 2020)
- 3.4 Global Ophthalmology for Age-related Macular Degeneration Diseases Average Price by Company (2016-2021)
- 3.5 Manufacturers Ophthalmology for Age-related Macular Degeneration Diseases Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size by Type
- 4.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Historic Market Review by Type (2016-2021)
- 4.1.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Type (2016-2021)
- 4.1.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Price by Type (2016-2021)
- 4.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Type (2022-2027)
- 4.2.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Price Forecast by Type (2022-2027)
5 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Size by Application
- 5.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Historic Market Review by Application (2016-2021)
- 5.1.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Market Share by Application (2016-2021)
- 5.1.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Price by Application (2016-2021)
- 5.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Sales Forecast by Application (2022-2027)
- 5.2.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Price Forecast by Application (2022-2027)
6 North America Ophthalmology for Age-related Macular Degeneration Diseases Market Facts & Figures
- 6.1 North America Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company
- 6.1.1 North America Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company (2016-2021)
- 6.1.2 North America Ophthalmology for Age-related Macular Degeneration Diseases Revenue by Company (2016-2021)
- 6.2 North America Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type
- 6.2.1 North America Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2022-2027)
- 6.3 North America Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application
- 6.3.1 North America Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application (2022-2027)
7 Europe Ophthalmology for Age-related Macular Degeneration Diseases Market Facts & Figures
- 7.1 Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company
- 7.1.1 Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company (2016-2021)
- 7.1.2 Europe Ophthalmology for Age-related Macular Degeneration Diseases Revenue by Company (2016-2021)
- 7.2 Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type
- 7.2.1 Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2022-2027)
- 7.3 Europe Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application
- 7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Ophthalmology for Age-related Macular Degeneration Diseases Market Facts & Figures
- 8.1 China Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company
- 8.1.1 China Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company (2016-2021)
- 8.1.2 China Ophthalmology for Age-related Macular Degeneration Diseases Revenue by Company (2016-2021)
- 8.2 China Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type
- 8.2.1 China Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2016-2021)
- 8.2.2 China Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2022-2027)
- 8.3 China Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application
- 8.3.1 China 244 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Ophthalmology for Age-related Macular Degeneration Diseases Market Facts & Figures
- 9.1 Japan Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company
- 9.1.1 Japan Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company (2016-2021)
- 9.1.2 Japan Ophthalmology for Age-related Macular Degeneration Diseases Revenue by Company (2016-2021)
- 9.2 Japan Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type
- 9.2.1 Japan Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2022-2027)
- 9.3 Japan Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application
- 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Market Facts & Figures
- 10.1 Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company
- 10.1.1 Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Revenue by Company (2016-2021)
- 10.2 Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type
- 10.2.1 Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application
- 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Ophthalmology for Age-related Macular Degeneration Diseases Market Facts & Figures
- 11.1 India Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company
- 11.1.1 India Ophthalmology for Age-related Macular Degeneration Diseases Sales by Company (2016-2021)
- 11.1.2 India Ophthalmology for Age-related Macular Degeneration Diseases Revenue by Company (2016-2021)
- 11.2 India Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type
- 11.2.1 India Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2016-2021)
- 11.2.2 India Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Type (2022-2027)
- 11.3 India Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application
- 11.3.1 India Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application (2016-2021)
- 11.3.2 India Ophthalmology for Age-related Macular Degeneration Diseases Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Ophthalmology for Age-related Macular Degeneration Diseases Business
- 12.1 DaVinci
- 12.1.1 DaVinci Corporation Information
- 12.1.2 DaVinci Business Overview
- 12.1.3 DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Products Offered
- 12.1.5 DaVinci Recent Development
- 12.2 Magnifying America
- 12.2.1 Magnifying America Corporation Information
- 12.2.2 Magnifying America Business Overview
- 12.2.3 Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Products Offered
- 12.2.5 Magnifying America Recent Development
- 12.3 Freedom Scientific
- 12.3.1 Freedom Scientific Corporation Information
- 12.3.2 Freedom Scientific Business Overview
- 12.3.3 Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Products Offered
- 12.3.5 Freedom Scientific Recent Development
- 12.4 LVI Low Vision International
- 12.4.1 LVI Low Vision International Corporation Information
- 12.4.2 LVI Low Vision International Business Overview
- 12.4.3 LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Products Offered
- 12.4.5 LVI Low Vision International Recent Development
- 12.5 NuEyes
- 12.5.1 NuEyes Corporation Information
- 12.5.2 NuEyes Business Overview
- 12.5.3 NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Products Offered
- 12.5.5 NuEyes Recent Development
- 12.6 Canadian Assistive Technologies
- 12.6.1 Canadian Assistive Technologies Corporation Information
- 12.6.2 Canadian Assistive Technologies Business Overview
- 12.6.3 Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Products Offered
- 12.6.5 Canadian Assistive Technologies Recent Development
- 12.7 Merlin Ultra
- 12.7.1 Merlin Ultra Corporation Information
- 12.7.2 Merlin Ultra Business Overview
- 12.7.3 Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Products Offered
- 12.7.5 Merlin Ultra Recent Development
- 12.8 HumanWare
- 12.8.1 HumanWare Corporation Information
- 12.8.2 HumanWare Business Overview
- 12.8.3 HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Products Offered
- 12.8.5 HumanWare Recent Development
13 Ophthalmology for Age-related Macular Degeneration Diseases Manufacturing Cost Analysis
- 13.1 Ophthalmology for Age-related Macular Degeneration Diseases Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Ophthalmology for Age-related Macular Degeneration Diseases
- 13.4 Ophthalmology for Age-related Macular Degeneration Diseases Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Ophthalmology for Age-related Macular Degeneration Diseases Distributors List
- 14.3 Ophthalmology for Age-related Macular Degeneration Diseases Customers
15 Market Dynamics
- 15.1 Ophthalmology for Age-related Macular Degeneration Diseases Market Trends
- 15.2 Ophthalmology for Age-related Macular Degeneration Diseases Drivers
- 15.3 Ophthalmology for Age-related Macular Degeneration Diseases Market Challenges
- 15.4 Ophthalmology for Age-related Macular Degeneration Diseases Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
Description
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected. Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to the rising incidence of age-related macular degeneration globally. As a result, there is a high demand for therapeutics to treat the condition. Pharmaceutical companies are leveraging this opportunity and are focusing on releasing drugs to treat age-related macular degeneration.
Market Analysis and Insights: Global Ophthalmology for Age-related Macular Degeneration Diseases Market
The global Ophthalmology for Age-related Macular Degeneration Diseases market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Ophthalmology for Age-related Macular Degeneration Diseases Scope and Market Size
The global Ophthalmology for Age-related Macular Degeneration Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmology for Age-related Macular Degeneration Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Portable
Desktop
Segment by Application
Wet AMD
Dry AMD
The Ophthalmology for Age-related Macular Degeneration Diseases market is analysed and market size information is provided by regions (countries). Segment by Application, the Ophthalmology for Age-related Macular Degeneration Diseases market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
DaVinci
Magnifying America
Freedom Scientific
LVI Low Vision International
NuEyes
Canadian Assistive Technologies
Merlin Ultra
HumanWare